May 30, 2019
Medicure Announces Renewal of its Normal Course Issuer Bid
May 27, 2019
Medicure Reports Financial Results for Quarter Ended March 31, 2019
May 22, 2019
Medicure Q1 2019 Results and Conference Call Dates
May 15, 2019
Medicure Appoints Ms. Manon Harvey to its Board of Directors
Apr 29, 2019
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2018
Apr 24, 2019
Medicure to Announce Fiscal Year End 2018 Financial Results on April 29, 2019
Feb 13, 2019
Medicure Provides Update on Release of Holdback Funds from Apicore Sale
Jan 28, 2019
Medicure Announces Agreement to Market ReDS(TM) Device for Congestive Heart Failure Patients in the United States
Nov 20, 2018
Medicure reports financial results for quarter ended September 30, 2018
Nov 16, 2018
Medicure Files Patent Infringement Action
Nov 14, 2018
Medicure Q3 2018 Results and Conference Call Dates
Aug 15, 2018
Medicure Reports Financial Results for Quarter Ended June 30, 2018
Aug 13, 2018
Medicure Announces FDA Approval of Acute Care Cardiovascular Drug Sodium Nitroprusside Injection
Aug 08, 2018
Medicure Q2 2018 Results and Conference Call Dates
May 23, 2018
Medicure Reports Financial Results for Quarter Ended March 31, 2018
May 17, 2018
Medicure Announces Normal Course Issuer Bid
May 17, 2018
Medicure Q1 2018 Results and Conference Call Dates
May 01, 2018
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2017
May 01, 2018
Medicure announces availability of ZYPITAMAG(TM) (pitavastatin) in the U.S.
Apr 24, 2018
Medicure to Announce Fiscal Year End 2017 Financial Results on April 30, 2018